Reiterate BUY with revised TP of Rs 548 Radico Khaitan (RDCK) reported healthy numbers for fourth consecutive quarter. In 2QFY19, revenues/ EBITDA/PAT grew by 15.5/39.5/76.3% YoY. Even in trailing 12m, RDCKs revenue/EBITDA and PAT grew at an accelerated pace of 20/44/85%. We expect the growth rate to taper from 3QFY19 as the base effect kicks-in yet it should remain healthy.